Adenosine Promotes the Recovery of Mice from the Cuprizone-Induced Behavioral and Morphological Changes while Effecting on Microglia and Inflammatory Cytokines in the Brain

Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations

(2018) Norbert Müller   SCHIZOPHRENIA BULLETIN

Multiple Sclerosis Pathology

(2018) Hans Lassmann   Cold Spring Harbor Perspectives in Medicine

N-acetylcysteine attenuates the cuprizone-induced behavioral changes and oligodendrocyte loss in male C57BL/7 mice via its anti-inflammation actions

(2017) Lin Zhang et al.   JOURNAL OF NEUROSCIENCE RESEARCH

A 2B adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway

(2017) Stefania Merighi et al.   PHARMACOLOGICAL RESEARCH

A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier

(2016) Do-Geun Kim et al.   JOURNAL OF CLINICAL INVESTIGATION

Toxicity of cuprizone a Cu2+ chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction

(2016) Mehrdad Faizi et al.   TOXICOLOGY MECHANISMS AND METHODS

Toxicity of cuprizone a Cu2+ chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction

(2016) Mehrdad Faizi et al.   TOXICOLOGY MECHANISMS AND METHODS

Loss of survival factors and activation of inflammatory cascades in brain sympathetic centers in type 1 diabetic mice

(2015) Ping Hu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats

(2015) Lisa C. Loram et al.   BRAIN BEHAVIOR AND IMMUNITY

Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy

(2015) Kali Janes et al.   BRAIN BEHAVIOR AND IMMUNITY

Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week

(2015) Yuan Shao et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Multiple sclerosis—a quiet revolution

(2015) Richard M. Ransohoff et al.   Nature Reviews Neurology

The cuprizone-induced changes in 1H-MRS metabolites and oxidative parameters in C57BL/6 mouse brain: Effects of quetiapine

(2015) Yinghua Xuan et al.   NEUROCHEMISTRY INTERNATIONAL

The role of inflammation in schizophrenia

(2015) Norbert Müller et al.   Frontiers in Neuroscience

Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination

(2014) Gelareh Vakilzadeh et al.   MOLECULAR NEUROBIOLOGY

Concurrent changes in 1H MRS metabolites and antioxidant enzymes in the brain of C57BL/6 mouse short-termly exposed to cuprizone: Possible implications for schizophrenia

(2014) Yinghua Xuan et al.   NEUROCHEMISTRY INTERNATIONAL

Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis

(2014) Jelle Praet et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination

(2013) Yasir A. Syed et al.   EMBO Molecular Medicine

The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis

(2013) Henrike J. Fischer et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Cuprizone short-term exposure: Astrocytic IL-6 activation and behavioral changes relevant to psychosis

(2013) Tomoaki Tezuka et al.   NEUROBIOLOGY OF DISEASE

Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype

(2013) S. Alex Marshall et al.   NEUROBIOLOGY OF DISEASE

Glia and epilepsy: excitability and inflammation

(2013) Orrin Devinsky et al.   TRENDS IN NEUROSCIENCES

G protein-coupled receptors as therapeutic targets for multiple sclerosis

(2012) Changsheng Du et al.   CELL RESEARCH

Rolipram promotes remyelination possibly via MEK-ERK signal pathway in cuprizone-induced demyelination mouse

(2012) Xiaojia Sun et al.   EXPERIMENTAL NEUROLOGY

Multiple sclerosis

(2012) Alyssa Nylander et al.   JOURNAL OF CLINICAL INVESTIGATION

Genetic inactivation of the adenosine A2Areceptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis

(2012) Shu-Qin Yao et al.   JOURNAL OF NEUROCHEMISTRY

L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the ‘collusion’ hypothesis for increased extracellular L-glutamate concentration in neuroinflammation

(2012) Junpei Takaki et al.   Journal of Neuroinflammation

Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis

(2012) Jeffrey H Mills et al.   Journal of Neuroinflammation

Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies

(2012) Ali Akbar Asghari et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis

(2012) M. Tutuncu et al.   Multiple Sclerosis Journal

Review: Activation patterns of microglia and their identification in the human brain

(2012) D. Boche et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination

(2012) Yanbo Zhang et al.   SCHIZOPHRENIA RESEARCH

Microglial Activation – Tuning and Pruning Adult Neurogenesis

(2012) Christine T. Ekdahl   Frontiers in Pharmacology

Purinergic signaling in embryonic and stem cell development

(2011) Geoffrey Burnstock et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Adenosine Receptor Signaling Modulates Permeability of the Blood-Brain Barrier

(2011) A. J. Carman et al.   JOURNAL OF NEUROSCIENCE

Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice

(2011) P. Chandran et al.   NEUROSCIENCE

Neuroinflammation in schizophrenia especially focused on the role of microglia

(2011) Akira Monji et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone.

(2009) Haiyun Xu et al.   BEHAVIORAL NEUROSCIENCE

Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia

(2009) Hong-Ju Yang et al.   BRAIN RESEARCH

Role of the innate immune system in the pathogenesis of multiple sclerosis

(2009) Roopali Gandhi et al.   JOURNAL OF NEUROIMMUNOLOGY

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia

(2009) Akira Monji et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse

(2008) Y ZHANG et al.   SCHIZOPHRENIA RESEARCH